Default object view. Click to create a custom template, Node ID: 169129, Object ID: 101413

Clinical outcomes of melanoma brain metastases treated with stereotactic radiosurgery and anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibito...

Clinical outcomes of melanoma brain metastases treated with stereotactic radiosurgery and anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitor, or conventional chemotherapy

No relation

Yes

No relation

No

15/09/2016 2:55 pm

Skin cancers
Melanoma

No